Koyfin Home > Directory > Health Care > Nymox Pharm Corp > Cash Flow from Operations

Nymox Pharm Corp Cash Flow from Operations Chart (NYMX)

Nymox Pharm Corp annual/quarterly Cash Flow from Operations from 2010 to 2020. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Nymox Pharm Corp Cash Flow from Operations for the quarter ending June 06, 2020 was $-2m a 12.57% decrease of 0m year over year
  • Nymox Pharm Corp Cash Flow from Operations for the last 12 months ending June 06, 2020 was $-8m a 9.13% decrease of -1m year over year
  • Nymox Pharm Corp Annual Cash Flow from Operations for 2019 was $-7m a -4.99% increase of 0m from 2018
  • Nymox Pharm Corp Annual Cash Flow from Operations for 2018 was $-8m a 20.45% decrease of -2m from 2017
  • Nymox Pharm Corp Annual Cash Flow from Operations for 2017 was $-6m a 27.46% decrease of -2m from 2016
Other Cash Flow Metrics:
  • Nymox Pharm Corp Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-1m a 97.41% decrease of -1m year over year
  • Nymox Pharm Corp Total Revenue for the quarter ending September 09, 2018 was $0m a -163.24% decrease of 0m year over year
View Chart On Koyfin

Quarterly NYMX Cash Flow from Operations Data

06/2020$-2m
03/2020$-2m
12/2019$-2m
09/2019$-2m
06/2019$-2m
03/2019$-2m
12/2018$-2m
09/2018$-2m
06/2018$-2m
03/2018$-2m

Annual NYMX Cash Flow from Operations Data

2019$-7m
2018$-8m
2017$-6m
2016$-5m
2015$-4m
2014$-6m
2013$-7m
2012$-8m
2011$-10m
2010$8m